News
12-11-2010, 05:04 AM
Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new study by researchers at The University of Texas MD Anderson Cancer Center in Houston...
More... (http://mnt.to/f/3NXy)
More... (http://mnt.to/f/3NXy)